VanEck Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
|
|||||
|
2025
Q1 | $8.35M | Buy |
|
|||||
|
2024
Q4 | $11M | Sell |
|
|||||
|
2024
Q3 | $14.3M | Buy |
|
|||||
|
2024
Q2 | $18.1M | Sell |
|
|||||
|
2024
Q1 | $24.9M | Sell |
|
|||||
|
2023
Q4 | $26.9M | Buy |
|
|||||
|
2023
Q3 | $23.5M | Buy |
|
|||||
|
2023
Q2 | $24.6M | Buy |
|
|||||
|
2023
Q1 | $29.6M | Buy |
|
|||||
|
2022
Q4 | $31.9M | Sell |
|
|||||
|
2022
Q3 | $24.8M | Buy |
|
|||||
|
2022
Q2 | $28M | Sell |
|
|||||
|
2022
Q1 | $51.4M | Buy |
|
|||||
|
2021
Q4 | $75.6M | Buy |
|
|||||
|
2021
Q3 | $74M | Buy |
|
|||||
|
2021
Q2 | $36.7M | Sell |
|
|||||
|
2021
Q1 | $29.5M | Buy |
|
|||||
|
2020
Q4 | $17.8M | Sell |
|
|||||
|
2020
Q3 | $24.9M | Sell |
|
|||||
|
2020
Q2 | $23.4M | Sell |
|
|||||
|
2020
Q1 | $13.5M | Buy |
|